Rhythm Pharmaceuticals, Inc. RYTM 深 沪
交易中 10-06 10:23:06 美东时间
91.685
-0.765
-0.83%
华盛通- 最 高114.75
- 今 开93.14
- 成交量 3.44万股
- 最 低 89.53
- 昨 收 92.45
- 总市值 462.03万
- 52周最高 122.20
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 74.50
- 委 比 18.92%
- 总股本 5.04万
- 历史最高 122.20
- 量 比 0.53
- 振 幅 27.28%
- 历史最低 1.10
- 每 手 1
- 风险率 9.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Rhythm Pharmaceuticals Presents Data From Multiple Presentations At Endocrine Society's Annual Meeting
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced new data from
06-16 04:04
Why Is Rhythm Pharma Stock Jumping Today?
Rhythm Pharma Phase 2 data showed improvements in BMI, body composition, hunger symptoms, and behavior in PWS patients.
06-16 00:51
Rhythm Pharmaceuticals Presents New Data At The Pediatric Endocrine Society Annual Meeting
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the presentation of
05-04 20:06
Rhythm Pharmaceuticals Discloses 18.8% BMI Drop In Rare Obesity Patients
Rhythm Pharma shares rise after Phase 3 data show strong BMI drop. FDA decision on obesity drug due by March 20.
03-02 22:41
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise
Rhythm Pharma rises after early Prader-Willi trial data show reduced hunger and BMI, supporting plans for a Phase 3 study of setmelanotide.
2025-12-12 02:17
Rhythm Pharmaceuticals's Earnings: A Preview
Rhythm Pharmaceuticals (NASDAQ:RYTM) is gearing up to announce its quarterly ea...
2025-11-04 03:01
Insights into Halozyme Therapeutics's Upcoming Earnings
Halozyme Therapeutics (NASDAQ:HALO) will release its quarterly earnings report ...
2025-11-01 02:02
国投证券-生物医药行业新药周观点：创新药5月进院数据更新，多个新纳入医保创新药快速进院中-250713
（转自：研报虎） 本周新药行情回顾： 2025年7月7日-2025年7月13日，新药板块涨幅前5企业：北海康成(114.5%)、前沿生物(41.4%)、君...
2025-07-13 21:23
